Sareum (LON:SAR) Stock Crosses Above 50 Day Moving Average – Here’s What Happened
by Doug Wharley · The Cerbat GemShares of Sareum Holdings plc (LON:SAR – Get Free Report) passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 20.84 and traded as high as GBX 24. Sareum shares last traded at GBX 24, with a volume of 118,957 shares.
Sareum Trading Up 4.3%
The firm has a market capitalization of £33.26 million, a P/E ratio of -6.15 and a beta of -1.08. The company has a 50 day simple moving average of GBX 20.84 and a two-hundred day simple moving average of GBX 17.81.
About Sareum
Sareum is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases. The Company aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.
Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the ‘cytokine storm’ immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).
Sareum also has an economic interest in SRA737, a clinical-stage oral, selective Checkpoint kinase 1 (Chk1) inhibitor that targets cancer cell replication and DNA damage repair mechanisms.